Managing Partner Mike Edelhart talks with Sabina Bruehlmann, CEO of Nimble, a company transforming personalized health through actionable intelligence from the gut microbiome.

In this episode, Sabina shares how Nimble’s novel science unlocks vast amounts of information that we’ve never been able to access before, the seemingly unlimited myriad of applications these invaluable insights will deliver, and her plans for their simple yet highly effective testing process to become as widely adopted as standard blood testing, greatly accelerating our understanding of our health and revolutionizing the entire industry.

Nimble just raised a $2M seed round - read all about it.